Although no changes in MDM2 levels were observed in unfractionated organotypic tumors (Figure S2C in Additional file1), analysis of tumor subgroups revealed a significant increase in MDM2 protein levels in Responder compared to Non Responder breast tumors (Figure 3A and D). This evidence concerns the gene MDM2 and breast neoplasm.